Advertisement
Research Article

Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

  • Fiona M. Blows equal contributor,

    equal contributor Contributed equally to this work with: Fiona M. Blows, Kristy E. Driver

    Affiliation: Department of Oncology, University of Cambridge, United Kingdom

    X
  • Kristy E. Driver equal contributor,

    equal contributor Contributed equally to this work with: Fiona M. Blows, Kristy E. Driver

    Affiliation: Department of Oncology, University of Cambridge, United Kingdom

    X
  • Marjanka K. Schmidt,

    Affiliation: Netherlands Cancer Institute, Amsterdam, The Netherlands

    X
  • Annegien Broeks,

    Affiliation: Netherlands Cancer Institute, Amsterdam, The Netherlands

    X
  • Flora E. van Leeuwen,

    Affiliation: Netherlands Cancer Institute, Amsterdam, The Netherlands

    X
  • Jelle Wesseling,

    Affiliation: Netherlands Cancer Institute, Amsterdam, The Netherlands

    X
  • Maggie C. Cheang,

    Affiliation: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, Canada

    X
  • Karen Gelmon,

    Affiliation: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, Canada

    X
  • Torsten O. Nielsen,

    Affiliation: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, Canada

    X
  • Carl Blomqvist,

    Affiliation: Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

    X
  • Päivi Heikkilä,

    Affiliation: Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland

    X
  • Tuomas Heikkinen,

    Affiliation: Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland

    X
  • Heli Nevanlinna,

    Affiliation: Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland

    X
  • Lars A. Akslen,

    Affiliation: The Gade Institute, Section for Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway

    X
  • Louis R. Bégin,

    Affiliation: Department of Pathology, McGill University and Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada

    X
  • William D. Foulkes,

    Affiliation: Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada

    X
  • Fergus J. Couch,

    Affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Xianshu Wang,

    Affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Vicky Cafourek,

    Affiliation: Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Janet E. Olson,

    Affiliation: Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Laura Baglietto,

    Affiliation: Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia

    X
  • Graham G. Giles,

    Affiliation: Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia

    X
  • Gianluca Severi,

    Affiliation: Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia

    X
  • Catriona A. McLean,

    Affiliation: The Alfred Hospital, Melbourne, Australia

    X
  • Melissa C. Southey,

    Affiliation: Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Australia

    X
  • Emad Rakha,

    Affiliation: Departments of Histopathology and Surgery, The Breast Unit, Nottingham City Hospital NHS Trust and University of Nottingham, Nottingham, United Kingdom

    X
  • Andrew R. Green,

    Affiliation: Departments of Histopathology and Surgery, The Breast Unit, Nottingham City Hospital NHS Trust and University of Nottingham, Nottingham, United Kingdom

    X
  • Ian O. Ellis,

    Affiliation: Departments of Histopathology and Surgery, The Breast Unit, Nottingham City Hospital NHS Trust and University of Nottingham, Nottingham, United Kingdom

    X
  • Mark E. Sherman,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Jolanta Lissowska,

    Affiliation: M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland

    X
  • William F. Anderson,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Angela Cox,

    Affiliation: Institute for Cancer Studies, University of Sheffield School of Medicine, Sheffield, United Kingdom

    X
  • Simon S. Cross,

    Affiliation: Academic Unit of Pathology, University of Sheffield School of Medicine, Sheffield, United Kingdom

    X
  • Malcolm W. R. Reed,

    Affiliation: Academic Unit of Surgical Oncology, University of Sheffield School of Medicine, Sheffield, United Kingdom

    X
  • Elena Provenzano,

    Affiliation: Department of Oncology, University of Cambridge, United Kingdom

    X
  • Sarah-Jane Dawson,

    Affiliation: Department of Oncology, University of Cambridge, United Kingdom

    X
  • Alison M. Dunning,

    Affiliations: Department of Oncology, University of Cambridge, United Kingdom, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

    X
  • Manjeet Humphreys,

    Affiliation: Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

    X
  • Douglas F. Easton,

    Affiliations: Department of Oncology, University of Cambridge, United Kingdom, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

    X
  • Montserrat García-Closas,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Carlos Caldas,

    Affiliation: Department of Oncology, University of Cambridge, United Kingdom

    X
  • Paul D. Pharoah mail,

    paul.pharoah@srl.cam.ac.uk

    Affiliations: Department of Oncology, University of Cambridge, United Kingdom, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

    X
  • David Huntsman

    Affiliation: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, Canada

    X
  • Published: May 25, 2010
  • DOI: 10.1371/journal.pmed.1000279

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.